AVODART® Alopecia Post-marketing Surveillance (PMS)

CompletedOBSERVATIONAL
Enrollment

712

Participants

Timeline

Start Date

April 29, 2010

Primary Completion Date

December 1, 2012

Study Completion Date

December 21, 2012

Conditions
Alopecia
Interventions
DRUG

Dutasteride

Basically there is no treatment allocation. Subjects who would be administered of dutasteride at their physicians' discretion will be enrolled. Dosage regimen will be recommended according to the prescribing information. Subjects will be enrolled consecutively.

Trial Locations (1)

301-721

GSK Investigational Site, Daejeon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY